United States - English - NLM (National Library of Medicine)

kreitchman pet center - ammonia n-13 (unii: 9oqo0e343z) (ammonia n-13 - unii:9oqo0e343z) - ammonia n-13 37.5 mci in 1 ml - ammonia n 13 injection is indicated for diagnostic positron emission tomography (pet) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease. none pregnancy category c animal reproduction studies have not been conducted with ammonia n 13 injection.  it is also not known whether ammonia n 13 injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.  ammonia n 13 injection should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk.  because many drugs are excreted in human milk and because of the potential for radiation exposure to nursing infants from ammonia n 13 injection, use alternative infant nutrition sources (e.g. stored breast milk or infant formula) for 2 hours (>10 half-lives of radioactive decay for n 13 isotope) after administration of the drug or avoid use of the drug, taking

United States - English - NLM (National Library of Medicine)

kreitchman pet center -

United States - English - NLM (National Library of Medicine)

kreitchman pet center - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f18 injection is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none pregnancy category c animal reproduction studies have not been conducted with fludeoxyglucose f 18 injection. it is also not known whether fludeoxyglucose f 18 injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. consider alternative diagnostic tests in a pregnant woman; administer fludeoxyglucose f 18 injection only if clearly needed. it is not known whether fludeoxyglucose f 18 injection is excreted in human milk. consider alternative diagnostic tests in women who are breast-feeding. use alternatives to breast feeding (e.g., stored breast milk or infant formula) for at least 10 half-lives of radioactive decay, if fludeoxyglucose f 18 injection is administered to a woman who is breast-feeding. the safety and effectiveness of fludeoxyglucose f 18 injection in pediatric patients with epilepsy is established on the basis of studies in adult and pediatric patients. in pediatric patients with epilepsy, the recommended dose is 2.6 mci. the optimal dose adjustment on the basis of body size or weight has not been determined. in the oncology or cardiology settings, the safety and effectiveness of fludeoxyglucose f 18 injection have not been established in pediatric patients.

Canada - English - Health Canada

teva canada limited - acyclovir - tablet - 200mg - acyclovir 200mg - nucleosides and nucleotides

Canada - English - Health Canada

teva canada limited - acyclovir - tablet - 400mg - acyclovir 400mg - nucleosides and nucleotides

Canada - English - Health Canada

teva canada limited - acyclovir - tablet - 800mg - acyclovir 800mg - nucleosides and nucleotides

Canada - English - Health Canada

glaxosmithkline inc - acyclovir - tablet - 400mg - acyclovir 400mg - nucleosides and nucleotides

Canada - English - Health Canada

glaxosmithkline inc - acyclovir - tablet - 800mg - acyclovir 800mg - nucleosides and nucleotides

Canada - English - Health Canada

teva canada limited - acyclovir - tablet - 800mg - acyclovir 800mg - nucleosides and nucleotides

Canada - English - Health Canada

teva canada limited - acyclovir - tablet - 400mg - acyclovir 400mg - nucleosides and nucleotides